Cargando…

Could Nanotheranostics be the Answer to the Coronavirus Crisis?

The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosselhy, Dina A., Assad, Mhd Adel, Sironen, Tarja, Elbahri, Mady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182285/
https://www.ncbi.nlm.nih.gov/pubmed/34141446
http://dx.doi.org/10.1002/gch2.202000112
_version_ 1783704177440980992
author Mosselhy, Dina A.
Assad, Mhd Adel
Sironen, Tarja
Elbahri, Mady
author_facet Mosselhy, Dina A.
Assad, Mhd Adel
Sironen, Tarja
Elbahri, Mady
author_sort Mosselhy, Dina A.
collection PubMed
description The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly diagnose COVID‐19 under the umbrella of nanotheranostics (i.e., smart, single agents combining nanodiagnostics and nanotherapeutics) are elaborated. The present work provides new insights into the promising incorporation of antiviral nanotheranostics into nanostructured materials, including electrospun fibers with tailored pore sizes and hydrophobicity, namely “superhydrophobic self‐disinfecting electrospun facemasks/fabrics (SSEF).” SSEFs are proposed as smart alternatives to address the drawbacks of N95 respirators. The challenges of coronavirus containment are underscored, literature is reviewed, and “top‐five suggestions” for containing COVID‐19 are offered, including: i) preventive appraisals—avoiding needless hospital admission and practicing frequent hand washing (from 20 to 60 s). ii) Diagnostics—highly recommending nanodiagnostics, detecting COVID‐19 within 10 min. iii) Therapeutics—expanding nanotherapeutics to treat COVID‐19 and bacterial co‐infections after safety assessments and clinical trials. iv) Multipronged and multinational, including China, collaborative appraisals. v) Humanitarian compassion to traverse this pandemic in a united way.
format Online
Article
Text
id pubmed-8182285
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81822852021-06-16 Could Nanotheranostics be the Answer to the Coronavirus Crisis? Mosselhy, Dina A. Assad, Mhd Adel Sironen, Tarja Elbahri, Mady Glob Chall Reviews The COVID‐19 pandemic is expanding worldwide. This pandemic associated with COVID‐19 placed the spotlight on how bacterial (e.g., methicillin‐resistant Staphylococcus aureus) co‐infections may impact responses to coronavirus. In this review the ways in which nanoparticles can contain and rapidly diagnose COVID‐19 under the umbrella of nanotheranostics (i.e., smart, single agents combining nanodiagnostics and nanotherapeutics) are elaborated. The present work provides new insights into the promising incorporation of antiviral nanotheranostics into nanostructured materials, including electrospun fibers with tailored pore sizes and hydrophobicity, namely “superhydrophobic self‐disinfecting electrospun facemasks/fabrics (SSEF).” SSEFs are proposed as smart alternatives to address the drawbacks of N95 respirators. The challenges of coronavirus containment are underscored, literature is reviewed, and “top‐five suggestions” for containing COVID‐19 are offered, including: i) preventive appraisals—avoiding needless hospital admission and practicing frequent hand washing (from 20 to 60 s). ii) Diagnostics—highly recommending nanodiagnostics, detecting COVID‐19 within 10 min. iii) Therapeutics—expanding nanotherapeutics to treat COVID‐19 and bacterial co‐infections after safety assessments and clinical trials. iv) Multipronged and multinational, including China, collaborative appraisals. v) Humanitarian compassion to traverse this pandemic in a united way. John Wiley and Sons Inc. 2021-03-24 /pmc/articles/PMC8182285/ /pubmed/34141446 http://dx.doi.org/10.1002/gch2.202000112 Text en © 2021 The Authors. Global Challenges published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Mosselhy, Dina A.
Assad, Mhd Adel
Sironen, Tarja
Elbahri, Mady
Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title_full Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title_fullStr Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title_full_unstemmed Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title_short Could Nanotheranostics be the Answer to the Coronavirus Crisis?
title_sort could nanotheranostics be the answer to the coronavirus crisis?
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182285/
https://www.ncbi.nlm.nih.gov/pubmed/34141446
http://dx.doi.org/10.1002/gch2.202000112
work_keys_str_mv AT mosselhydinaa couldnanotheranosticsbetheanswertothecoronaviruscrisis
AT assadmhdadel couldnanotheranosticsbetheanswertothecoronaviruscrisis
AT sironentarja couldnanotheranosticsbetheanswertothecoronaviruscrisis
AT elbahrimady couldnanotheranosticsbetheanswertothecoronaviruscrisis